Human Microbiome Market

1
Global Human Microbiome Market Is Estimated To
Witness High Growth Owing To Advances In
Microbiome Research And Increasing
Prevalence Of Chronic Diseases
Human Microbiome Market A) Market
Overview The human microbiome refers to
the collection of microorganisms, including
bacteria, fungi, viruses, and other microbes that
reside in and on the human body. The microbiome
plays a crucial role in maintaining overall
health and is involved in various physiological
processes such as digestion, metabolism, and
immune system modulation. Recent advancements
in microbiome research have revealed its
potential as a therapeutic target for the
treatment of various diseases. The market
offers a wide range of products associated
with the human microbiome, including
probiotics, prebiotics, postbiotics, and
microbiome sequencing services. Probiotics
are live microorganisms that confer health
benefits when consumed, while
prebiotics are non-digestible fibers that promote
the growth of beneficial bacteria in the
2

• gut. The global Human Microbiome Market is
  estimated to be valued at USD 91,075.4 billion in
  2021 and is expected to exhibit a CAGR of 18.9
  over the forecast period 2021- 2028
• Postbiotics are metabolic byproducts of
  probiotics that have bioactive
  properties. Microbiome sequencing services
  involve analyzing the composition and function of
  the microbiome using high-throughput sequencing
  techniques.
• B) Market Dynamics
• Driver Advances in Microbiome Research
  Advancements in DNA sequencing technologies
  and bioinformatics have led to a better
  understanding of the human microbiome. This
  has enabled the identification of specific
  microbial strains and their functions,
  contributing to the development of
  targeted therapies. The advent of
  metagenomics and multi-omics approaches has
  opened new avenues for studying the role of the
  microbiome in various diseases and has led
  to the discovery of novel therapeutic
  targets.
• For example, researchers have identified
  associations between imbalances in the gut
  microbiome and conditions such as obesity,
  diabetes, inflammatory bowel disease, and certain
  types of cancer. This has paved the way for the
  development of microbiome-based interventions,
  including fecal microbiota transplantation (FMT)
  and microbial therapeutics.
• Opportunity Increasing Prevalence of Chronic
  Diseases
• The prevalence of chronic diseases, such as
  diabetes, cardiovascular diseases, and
  gastrointestinal disorders, is on the rise
  globally. These diseases are often associated
  with dysbiosis, an imbalance in the
  composition and function of the microbiome.
  Researchers are exploring the potential of
  restoring the healthy microbiome as a
  therapeutic approach for managing chronic
  diseases.
• For instance, FMT has shown promising results in
  treating recurrent Clostridium difficile
  infection, a severe gastrointestinal
  infection that is often resistant to
  conventional antibiotics. Furthermore,
  microbiome-based therapies have the potential
  to reduce the risk of chronic diseases by
  modulating immune responses, improving
  metabolism, and enhancing overall gut health.
• C) Segment Analysis
• Among the various segments in the Human
  Microbiome Market, the probiotics segment is
  expected to dominate due to its wide range
  of applications and growing consumer
  awareness about the health benefits of
  probiotics. Probiotics are extensively used in
  the treatment of gastrointestinal disorders,
  immune system modulation, and vaginal health

maintenance.
3

• PEST Analysis
• Political Regulatory frameworks and policies
  governing the development and marketing of
  microbiome-based products may impact market
  growth.
• Economic Increasing healthcare expenditure,
  particularly in emerging economies, is
  expected to drive the demand for microbiome-based
  therapies.
• Social Growing consumer awareness about the
  importance of gut health and the role of the
  microbiome in overall well-being is driving the
  demand for microbiome products.
• Technological Advances in DNA sequencing
  technologies and bioinformatics have
  revolutionized microbiome research and have
  facilitated the development of targeted
  microbiome-based therapies.
• Key Takeaways
• The global Human Microbiome Market is expected to
  witness high growth, exhibiting a CAGR of 18.9
  over the forecast period, due to increasing
  advances in microbiome research and the rising
  prevalence of chronic diseases.
• North America is expected to dominate the market,
  attributed to the presence of leading biotech
  companies, well-established healthcare
  infrastructure, and a high prevalence of chronic
  diseases.
• Key players operating in the global aHuman
  Microbiome Market include Finch Therapeutics
  Group, Inc., Assembly Biosciences, Inc